AVR · ASX

Anteris Technologies Ltd. (ASX:AVR)

AU$7.23

 0.25 (3.582%)
ASX:Live
09/05/2025 12:34:06 PM
Hammer Bullish HALO Ords HALO Capital Efficiency GROWTH AUS Big Candle +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AVR Overview

AVR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About AVR

Website

N/A

Telephone

61.7.3152.3200

Address

Suite 302, Level 3 9 Sherwood Road Toowong Tower Toowong, Queensland (QLD) 4066

Description

Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. It operates through the following geographical segments: Australia, United States, and Switzerland. It manufactures, distributes, and sells ADAPT and DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.

AVR Price Chart

Key Stats

Market Cap

AU$241.98M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.26 - 21.25

Trade Value (12mth)

AU$60,810.00

1 week

-6.93%

1 month

54.42%

YTD

-17%

1 year

-66.87%

All time high

186.88

Key Fundamentals

EPS 3 yr Growth

67.00%

EBITDA Margin

%

Operating Cashflow

-$51m

Free Cash Flow Return

-234.70%

ROIC

-307.30%

Interest Coverage

-160.10

Quick Ratio

2.50

Other Data

Shares on Issue (Fully Dilluted)

18m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AVR Announcements

Latest Announcements

Date Announcements

07 May 25

Statement of CDIs on issue - AVR

×

Statement of CDIs on issue - AVR

30 April 25

SEC Form 10-K/A

×

SEC Form 10-K/A

29 April 25

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

07 April 25

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

07 April 25

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

02 April 25

Statement of CDIs on issue - AVR

×

Statement of CDIs on issue - AVR

31 March 25

Clinical Milestone - 100 patients treated with DurAVR THV

×

Clinical Milestone - 100 patients treated with DurAVR THV

27 March 25

Notification regarding unquoted securities - AVR

×

Notification regarding unquoted securities - AVR

27 March 25

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

27 March 25

Cleansing Notice

×

Cleansing Notice

21 March 25

Anteris Reports One-Year Patient Outcomes for DurAVR THV

×

Anteris Reports One-Year Patient Outcomes for DurAVR THV

21 March 25

Change of Directors' Interest Notice

×

Change of Directors' Interest Notice

13 March 25

Annual Report to shareholders

×

Annual Report to shareholders

13 March 25

2024 Financial Results and Corporate Update

×

2024 Financial Results and Corporate Update

13 March 25

Corporate Governance Statement and Appendix 4G

×

Corporate Governance Statement and Appendix 4G

11 March 25

Cleansing Notice

×

Cleansing Notice

07 March 25

Initial Director's Interest Notice

×

Initial Director's Interest Notice

06 March 25

Director Appointment/Resignation

×

Director Appointment/Resignation

05 March 25

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

05 March 25

Statement of CDIs on issue - AVR

×

Statement of CDIs on issue - AVR

28 February 25

ASX waiver from requirement to lodge an Appendix 4E

×

ASX waiver from requirement to lodge an Appendix 4E

18 February 25

Notification of cessation of securities - AVR

×

Notification of cessation of securities - AVR

13 February 25

Release of Australian Taxation Office Class Rulings

×

Release of Australian Taxation Office Class Rulings

12 February 25

Application for quotation of securities - AVR

×

Application for quotation of securities - AVR

03 February 25

Statement of CDIs on issue - AVR

×

Statement of CDIs on issue - AVR

AVR Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -3.09 -3.32 -4.31 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -3.09 -3.32 -4.31 Lock Lock Lock
     Growth % Lock Lock Lock Lock -19.6 -7.4 -30.0 Lock Lock Lock
     PE X Lock Lock Lock Lock 1.5 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -1.81 -2.81 -3.20 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -2.64 -3.09 -3.52 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.7 -54.9 -13.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -20.4 -13.9 -18.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 1.29 0.95 1.61 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 1.19 0.89 1.53 Lock Lock Lock
     Growth % Lock Lock Lock Lock 647.9 -25.5 72.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 7 13 16 Lock Lock Lock
Basic m Lock Lock Lock Lock 7 13 16 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 8 5 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.1 -41.1 -10.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 14 26 36 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -9 -22 -35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.5 -144.9 -63.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -113.1 -470.2 -857.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 213 570 957 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -22 -46 -69 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.9 -110.8 -50.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -277.9 -994.4 -1,675.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -23 -47 -72 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.2 -106.0 -51.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -295.3 -1,032.4 -1,743.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -24 -46 -70 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -23 -44 -67 Lock Lock Lock
     Growth % Lock Lock Lock Lock -50.0 -93.6 -51.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -294.0 -966.0 -1,637.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -19 -39 -51 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 2 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -1 -4 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 37 31 73 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -20 -41 -55 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.5 -110.9 -33.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.5 -9.0 -13.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 21 14 31 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 29 23 46 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -16 -12 -28 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 15 10 17 Lock Lock Lock
Equity $m Lock Lock Lock Lock 14 13 29 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 15 14 30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 356.3 -6.1 116.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -77.7 -188.8 -147.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -159.7 -335.5 -235.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -175.2 -273.1 -314.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -254.4 -309.7 -307.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -208.9 -272.3 -234.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -14.4 -47.2 -160.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.7 0.3 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -108.5 -93.8 -99.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.0 2.4 2.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.9 2.3 2.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 82.4 76.4 85.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -145.3 -517.1 -372.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.7 1.9 2.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 22.9 40.8 67.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 0.4 0.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 39.4 55.5 111.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.2 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.2 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -311.7 -996.6 -1,705.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -82.4 -194.8 -153.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -77.7 -188.8 -147.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.1 1.8 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -159.7 -335.5 -235.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -159.7 -335.5 -235.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 16.0 8.9 5.4 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 97.7 191.7 155.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 113.6 200.6 161.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 41.9 39.5 33.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 71.7 161.1 128.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVR Shortsell

Frequently Asked Questions

The current share price of Anteris Technologies Ltd. (AVR:ASX) is AU$7.23.
The 52-week high share price for Anteris Technologies Ltd. (AVR:ASX) is AU$21.25.
The 52-week low share price for Anteris Technologies Ltd. (AVR:ASX)? is AU$4.26.
Anteris Technologies Ltd. (AVR:ASX) does not pay a dividend.
Anteris Technologies Ltd. (AVR:ASX) does not pay a dividend.
Anteris Technologies Ltd. (AVR:ASX) has a franking level of 0.0%.
Anteris Technologies Ltd. (AVR:ASX) is classified in the Healthcare.
The current P/E ratio for Anteris Technologies Ltd. (AVR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.